Brief: Enorama Pharma Q2 Net Sales SEK 733,000
20/08/2025 12:42
Aug 20 (Reuters) - Enorama Pharma AB ERMA.ST: Q2 NET SALES AMOUNTED TO SEK 733,000 Q2 OPERATING LOSS AMOUNTED TO SEK -15,321 THOUSAND Source text: ID:nWkr1nrQnv Further company coverage: ERMA.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO